Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/21168
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPadrón-Nieves, Maritza-
dc.contributor.authorPonte-Sucre, Alicia-
dc.date.accessioned2021-06-24T20:16:08Z-
dc.date.available2021-06-24T20:16:08Z-
dc.date.issued2021-06-24-
dc.identifier.isbn978-1-0716-0294-2-
dc.identifier.urihttp://hdl.handle.net/10872/21168-
dc.description.abstractMarkers to diagnose chemoresistance in infecting Leishmania parasites are urgently required. This is fundamental for patients who do not heal during or after treatment, as they are unresponsive, or patients who relapse at the end of the therapy, suffering from therapeutic failure. Glucose utilization is an indicator of cell viability that closely associates with metabolic activity. In Leishmania, glucose is a source of carbon atoms and is imported into the cell through specific transporters. In experimentally developed chemoresistant Leishmania parasites a significant decrease of the expression of glucose transporters as well as in the cellular accumulation glucose has been described. Alternatively, the electrical membrane potential is an essential parameter for the formation of the electromotive force needed for the acquisition of important nutrients and solutes (e.g., glucose) by cells, and changes in glucose concentration are suggested to constitute a physiological adaptation associated with a chemoresistant phenotype of Leishmania parasites. Here we describe easy methods to measure glucose uptake and the membrane potential in isolates from patient suffering leishmaniasis. Correlation between both parameters might be helpful to identify chemoresistant parasites. Results suggest that the measured kinetics of glucose utilization rate can be correlated with the plasma membrane potential and together used to differentiate between the performance of wild-type and reference parasites on the one hand and parasites isolated from patients with therapeutic failure on the otheren_US
dc.description.sponsorshipThe authors are grateful for the support conferred by the Alexander von Humboldt Foundation and the Siebold-Collegium Institute for Advanced Studies, University of Wu¨rzburg, Germany, to Alicia Ponte-Sucre. The authors are grateful to the Universidad Central de Venezuela Council for Research, grants CDCH-UCV PI-09-8717-2013/1 and PG-09-8646- 2013/1. This project was approved by the Ethical Committee of the Institute of Biomedicine, Universidad Central de Venezuelaen_US
dc.language.isoenen_US
dc.relation.ispartofseriesMethods Mol Biol;2020;2116:755-769. doi: 10.1007/978-1-0716-0294-2_44. PMID: 32221953 Paul Michels, Michael Ginger, Dan Zilberstein, editors,-
dc.subjectbis-oxonolen_US
dc.subjectdrug-resistanceen_US
dc.subjectdrug-resistance markersen_US
dc.subjectglucose-uptakeen_US
dc.subjectLeishmaniaen_US
dc.subjectplasma membrane potentialen_US
dc.subjecttherapeutic failureen_US
dc.titleCellular Markers for the Identification of Chemoresistant Isolates in Leishmania.en_US
dc.typeBook chapteren_US
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Padron-Nieves y Ponte-Sucre 2020.pdf512.6 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.